BackgroundLorlatinib is a new generation ALK kinase inhibitor. We describe a 52-year-old patient with ALK-positive advanced lung adenocarcinoma who achieved remission after multi-line therapy combined with paraneoplastic leukemoid reaction treated with ...
Jingdan Pang (17848661) +5 more
core +1 more source
Leukemoid Reaction in a Severe COVID-19 Patient. [PDF]
Sene DR, Watashi DM.
europepmc +1 more source
A Paraneoplastic Leukemoid Reaction in Primary Lung Sarcoma. [PDF]
Al Sbihi AF +4 more
europepmc +1 more source
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma. [PDF]
Duminuco A +9 more
europepmc +1 more source
Leukemoid Reaction: Presentation of Two Cases
The leukemoid reaction is defined by the presence in peripheral blood of white cells above 50,000/mm3 or neutrophils above 30,000/mm3 . The frequency varies between 1.3 and 15% of newborns admitted to neonatal intensive care units [1]. It usually appears
Arca Díaz, Gemma +2 more
core
Elevated serum AST and LDH levels are associated with infant death in premature babies with neonatal leukemoid reaction: a cohort study. [PDF]
Liu R +8 more
europepmc +1 more source
Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis. [PDF]
Pahadiya HR, Lakhotia M.
europepmc +1 more source
Fever and leukemoid reaction in bladder cancer: A case report. [PDF]
Huang T +8 more
europepmc +1 more source
A 53-Year-Old Male Smoker With Advanced Oral Squamous Cell Carcinoma Associated With Paraneoplastic Leukemoid Reaction. [PDF]
Yeh CY.
europepmc +1 more source
Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report. [PDF]
Li J +6 more
europepmc +1 more source

